Amarin Corp Plc (AMRN)

[sts66]

Process changes? Wonder what that entails? This is saying GV will have to submit data from the new batches of API to the FDA for approval of the process change, could be a hangup. Bad news for AMRN if it's not - GV already has 17% market shr, 300 MT is enough to get over 50% - the Hikma lawsuit won't be far enough along in a year to prevent a huge surge in GV sales, insurers blocking anything but R-IT sales are our only hope in the US.